Comment on 'Can Angiotensin Receptor-blocking Drugs Perhaps Be Harmful in the COVID-19 Pandemic?'
Overview
Authors
Affiliations
Geca T, Wojtowicz K, Guzik P, Gora T Int J Environ Res Public Health. 2022; 19(11).
PMID: 35682137 PMC: 9180541. DOI: 10.3390/ijerph19116555.
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H Med Hypotheses. 2021; 152:110609.
PMID: 34048987 PMC: 8114589. DOI: 10.1016/j.mehy.2021.110609.
Viswanathan V, Puvvula A, Jamthikar A, Saba L, Johri A, Kotsis V World J Diabetes. 2021; 12(3):215-237.
PMID: 33758644 PMC: 7958478. DOI: 10.4239/wjd.v12.i3.215.
Angiotensin II, III, and IV may be important in the progression of COVID-19.
Cure E, Ilcol T, Cumhur Cure M J Renin Angiotensin Aldosterone Syst. 2020; 21(4):1470320320972019.
PMID: 33169633 PMC: 7658520. DOI: 10.1177/1470320320972019.
Reply: Possible impact of membrane ACE2 expression on COVID-19 infection.
Esler M, Esler D J Hypertens. 2020; 38(6):1192-1194.
PMID: 32371814 PMC: 7236858. DOI: 10.1097/HJH.0000000000002484.